We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$21.9B
AUM Growth
+$21.9B
Cap. Flow
-$417M
Cap. Flow %
-1.9%
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$89.3M
2
KEYS icon
Keysight
KEYS
+$86M
3
NKE icon
Nike
NKE
+$78.3M
4
APH icon
Amphenol
APH
+$76.5M
5
CMCSA icon
Comcast
CMCSA
+$72.3M

Top Sells

Rank Stock Value
1
CE icon
Celanese
CE
+$108M
2
MNST icon
Monster Beverage
MNST
+$97.8M
3
SBUX icon
Starbucks
SBUX
+$79.7M
4
TXN icon
Texas Instruments
TXN
+$67.3M
5
CNC icon
Centene
CNC
+$64.3M

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UFCS icon
1851
United Fire Group
UFCS
$1.35B
$14K ﹤0.01%
335
+74
+28% +$3.31K
CMRX
1852
DELISTED
Chimerix, Inc.
CMRX
$14K ﹤0.01%
6,992
– –
LBAI
1853
DELISTED
Lakeland Bancorp Inc
LBAI
$14K ﹤0.01%
844
– –
RUTH
1854
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
$14K ﹤0.01%
682
+546
+401% +$12K
CSII
1855
DELISTED
Cardiovascular Systems, Inc.
CSII
$14K ﹤0.01%
298
+103
+53% +$4.69K
NTUS
1856
DELISTED
Natus Medical Inc
NTUS
$14K ﹤0.01%
426
+100
+31% +$3.21K
NP
1857
DELISTED
Neenah, Inc. Common Stock
NP
$14K ﹤0.01%
206
+50
+32% +$3.4K
FLXN
1858
DELISTED
Flexion Therapeutics, Inc.
FLXN
$14K ﹤0.01%
698
– –
VRTU
1859
DELISTED
Virtusa Corporation
VRTU
$14K ﹤0.01%
311
+157
+102% +$6.4K
AGI icon
1860
Alamos Gold
AGI
$12.1B
$13K ﹤0.01%
2,183
– –
ALV icon
1861
Autoliv
ALV
$9.09B
$13K ﹤0.01%
162
-62
-28% -$5.07K
AMPH icon
1862
Amphastar Pharmaceuticals
AMPH
$888M
$13K ﹤0.01%
676
+131
+24% +$2.51K
AORT icon
1863
Artivion
AORT
$1.31B
$13K ﹤0.01%
489
+143
+41% +$3.51K
ASR icon
1864
Grupo Aeroportuario del Sureste
ASR
$8.14B
$13K ﹤0.01%
71
-5
-7% -$849
BBWI icon
1865
Bath & Body Works
BBWI
$4.13B
$13K ﹤0.01%
896
+343
+62% +$4.95K
BCH icon
1866
Banco de Chile
BCH
$20.4B
$13K ﹤0.01%
631
-6
-0.9% -$146
CAL icon
1867
Caleres
CAL
$447M
$13K ﹤0.01%
565
+207
+58% +$4.68K
CRS icon
1868
Carpenter Technology
CRS
$27.8B
$13K ﹤0.01%
266
-534
-67% -$27.4K
DINO icon
1869
HF Sinclair
DINO
$16.1B
$13K ﹤0.01%
258
-187
-42% -$9.91K
EC icon
1870
Ecopetrol
EC
$32.5B
$13K ﹤0.01%
695
– –
FELE icon
1871
Franklin Electric
FELE
$4.85B
$13K ﹤0.01%
240
+87
+57% +$4.6K
FL
1872
DELISTED
Foot Locker
FL
$13K ﹤0.01%
372
– –
FSLR icon
1873
First Solar
FSLR
$21.8B
$13K ﹤0.01%
235
-109
-32% -$5.99K
GBX icon
1874
The Greenbrier Companies
GBX
$1.6B
$13K ﹤0.01%
403
+118
+41% +$3.53K
GKOS icon
1875
Glaukos
GKOS
$8.89B
$13K ﹤0.01%
244
– –
73 74
75
76 77

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
  • Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
  • Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
  • Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
  • Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
  • Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.